Strata Oncology operates as a precision oncology company. The company offers services that integrate molecular profiling, decision support, and clinical trial participation into routine practice, providing care for cancer patients. Strata Oncology primarily serves healthcare providers, health systems, biopharma, and patients. It was founded in 2015 and is based in Ann Arbor, Michigan.

Pangea Biomed develops a multi-cancer and multi-therapy response predictor. It combines machine learning and deep ribonucleic acid (RNA) analysis to map tumor molecular signatures for personalized cancer care. The company aims to bring precision oncology to cancer patients through oncology drug development, and the empowerment of oncologists to treat patients. It was founded in 2018 and is based in Tel Aviv, Israel.

Perthera operates as a healthcare artificial intelligence company focusing on advancing precision medicine. The company offers an artificial intelligence (AI) enabled platform utilizing patient history and multi-omic testing results to match cancer patients with ranked therapy options, and accelerates clinical and therapeutic innovation. It was formerly known as Personalized Cancer Therapy. It primarily serves the healthcare industry in the oncology sector. It was founded in 2012 and is based in McLean, Virginia.

Syapse focuses on transforming real-world evidence into actionable insights within the healthcare sector. The company empowers healthcare organizations to collaborate and deliver patient insights to improve care, particularly for cancer patients. Syapse's services are primarily utilized by healthcare providers and organizations seeking to enhance patient outcomes through data-driven insights. Syapse was formerly known as BDLicense. It was founded in 2008 and is based in San Francisco, California.

First Ascent Biomedical specializes in personalized cancer treatment, utilizing a combination of artificial intelligence, functional drug testing, and genomics. The company offers a drug prediction platform and decision support system that provides individualized treatment plans for cancer patients by identifying tumor vulnerabilities and testing drugs on the patient's own cells. First Ascent Biomedical primarily serves the medical oncology sector, offering solutions to patients, physicians, and the pharmaceutical industry. It was founded in 2018 and is based in Beaverton, Oregon.

Molecular You is a developer of a digital personalized health platform designed to deliver comprehensive health information and individualized health action plans. Molecular You leverages a multi-biomarker analytics platform that includes proteomic and metabolomic data to create highly accurate predictive risk profiles for over 26 health conditions. Molecular You's AI-powered platform analyzes a comprehensive set of over 250 biomarkers to provide early detection of potential health risks and deliver personalized nutrition, exercise, and supplement recommendations through a user-friendly web interface. This approach not only enhances individual health outcomes but also supports healthcare providers in delivering value-based care by improving health assessment, patient engagement, and preventative health strategies. Through its emphasis on precision medicine, Molecular You advances the field of personalized medicine by tailoring health insights and interventions to each individual's unique molecular profile. It was founded in 2014 and is based in Vancouver, Canada.